Fundraise / allotmentMajor development· Adverse for the businessFiled on BSE ·

Sammaan Capital Q4 net loss ₹8,101.41 crore; board authorises ₹10,000 crore debt raise

Sammaan Capital · Finance

Arthneeti Research DeskPublished 1 min read
₹8,101 CrFundraise / allotment

Key highlights

  • Q4 FY26 (quarter ended March 31, 2026) net loss of ₹8,101.41 crore vs profit of ₹324.04 crore in the year-earlier quarter, after an exceptional item of ₹6,499.17 crore.
  • Board authorised fundraise via debentures, bonds, ECBs and other non-convertible securities aggregating up to ₹10,000 Crores, subject to regulatory approvals.
  • Moody's upgraded long-term CFR to B1 with Positive Outlook; CRISIL upgraded long-term debt to AA+/Stable; CARE upgraded it to AA+/Stable and reaffirmed CARE A1+ on CP and short-term NCDs.

Why it's rated major development: the year-on-year change is 100% (20% or more for adverse news)

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Outcome Of Board Meeting Held On May 20, 2026.

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Sammaan Capital

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.